Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

10,627 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,473
Recruiting: 1,285
Ph III recruiting: 130
Growth YoY: +6.4%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,641)

clinicaltrialsPublishedShowing 301–350 of 10,627 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04314752	Development of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities(MEDULLA)	recruiting	—	4,000	University of California, DavisOTHER	1	Sep 14, 2026	clinicaltrials
NCT04544592	UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL	recruiting	Phase 1 / Phase 2	45	University of Colorado, DenverOTHER	1	Sep 14, 2026